ISSN: 2329-8901
CEO, Finnoflag Oy University of Helsinki, Finland
In 1986 he was the first scientist in a project between the University of Helsinki and Valio dairies corporation. This project shaped the Valio's entry into the probiotics business, leading to the acquisition of Lactobacillus rhamnosus GG strain and its successful launching as the leading star of the field. After his graduation Elias Hakalehto participated for one year an intensive course "Postgraduate Diploma in Biotechnology" which approximately equaled with M.Sci degree.
Market Analysis
Functional Food & Advanced Nutraceuticals
Author(s): Elias Hakalehto*